SlideShare a Scribd company logo
MATOSHRI EDUCATIONS SOCIETY’S
M.A.B.D DIPLOMA COLLEGE
OF PHARMACY
Babhulgaon, Tal.- Yeola, Dist.- Nashik, Maharashtra 423401
PHARMACEUTICS-II
STERILE DOSAGE FORM
(Ophthalmic Dosage form)
By
Prof. Mr. Deore A. B
M.Pharm (Pharmaceutics)
STERILE DOSAGE FORM
STERILE DOSAGE FORM
Ophthalmic dosage form
Definition-
Ophthalmic dosage form can be defined as they are the
sterile dosage form meant for instillation into the eye in the
space between eye lids and the eye balls is called as
ophthalmic dosage form.
STERILE DOSAGE FORM
ADVANTAGE:
 They are easily administered by the nurse.
 They are easily administered by the patient himself.
 They have the quick absorption and effect.
 less visual and systemic side effects.
 Increased shelf life.
 better patient compliance.
STERILE DOSAGE FORM
DISADVANTAGES
 The very short time the solution stays at the eye surface.
 Its poor bioavailability.
 The instability of the dissolved drug.
 The necessity of using preservative.
STERILE DOSAGE FORM
The most important thing about these products are these
products must be sterile and should be prepared under the
same conditions and by the same methods like other
parenteral Parenteral dosage form. Ophthalmic dosage form
include-
 Eye drops
 Eye lotions
 Eye ointments
 Eye suspension.
 Contact lens solutions
STERILE DOSAGE FORM
Ophthalmic dosage forms
Types and characteristics
1) Liquid preparations: (eye drops and eye lotion)
2) Semisolid dosage forms: (ointment creams and gels)
applied to the margin of thee yelid or in the conjunctival
sac.
3) Solid dosage form: applied to the eye surface to produce
modified release dosage form.
STERILE DOSAGE FORM
Ideal characteristics of Ophthalmic dosage form
 Ophthalmic products are required to be sterile and free
from particulate matter.
 They could be presented as single use or multiple use
containers.
 If multidose container preservative should be added.
 It should have almost neutral pH (pH 7)
STERILE DOSAGE FORM
Ophthalmic preparations must possess the following
properties as mentioned below-
 Foreign particles-
All the ophthalmic preparations must be free from foreign
particles, fibres and filaments. This types of preparations
should be clarified very carefully by passing these through
bacteria proof filters like membrane filters and sintered
glass filters. The paeticle size of the eye suspension should
be in an ultra fine state of subdivision to avoid irritations. A
separate filter should use for different ophthalmic products
to avoid the contamination.
STERILE DOSAGE FORM
 Viscosity-
Various thickening agents are added in the ophthalmic
preparation to prolong the contact time of the drug in the
eye. Some commonly used thickening agents are polyvinyl
alcohol (1-4%), polyethylene glycol, methylcellulose,
carboxy methylcellulose etc. These agents improve the
viscosity of the ophthalmic preparation.
STERILE DOSAGE FORM
What are the characteristics of an Ideal thickening agent?
 They must be easy to filter.
 They should be easy to sterilize.
 It should be compatible with other ingredients.
 Thickening agents should possess refractive index and
clarity level.
 The thickening agents are not used in the formulation of
eye drops and eye lotions which are used during or after
surgery because of some possible adverse effects on the
interior of the eye.
STERILE DOSAGE FORM
 Tonicity-
Ophthalmic products should be isotonic with lachrymal
secretion to avoid irritation and discomfort. It has been
noticed that eye can tolerate tonicity in the range from
0.5 to 2% sodium chloride. There are some isotonic
vehicles which are used to prepare ophthalmic
preparations like 1.9% boric acid, sodium acid phosphate
buffer.
STERILE DOSAGE FORM
 pH of the preparations-
pH plays important role in therapeutic activity, solubility,
stability and comfort to the patient. Eye can tolerate
solution having wide range of pH provided they are not
strongly buffered, since the tears will rapidly restore the
normal pH value of the eye. Tears have the pH of 7.4.
Alkaloidal salt solutions are stable at pH 2 to 3 but this is
irritant to eye. Alkaloids get precipitated at pH above 7
and make problems in the formulations.
STERILE DOSAGE FORM
 Sterility:
The most important properties of the ophthalmic
preparation is that they must be sterile when prepared. A
very common gram negative bacteria named Pseudomonas
aeruginosa which is generally present in the ophthalmic
preparations. It may cause serious infection of cornea. It
can cause total loss of eye sight within 24-48 hours.
To maintain the sterility in multidose container containing
ophthalmic preparation a suitable preservative is added.
The preservative which is used must be non toxic, non
irritant, and must be compatible with the medicaments.
The ophthalmic products are sterilised by autoclaving,
filtration, addition of bactericide at low temperature and
by passing through bacteria proof filters.
STERILE DOSAGE FORM
 Surface activity-
The vehicles which are used in ophthalmic preparation
must have good wetting ability to penetrate cornea and
other tissues. Certain surfactants or wetting agents are
added which are found suitable for ophthalmic
preparation. It should not cause any damage to the tissues
of eye. Some surfactants which are generally used are
benzalkonium chloride, polysorbate 20, polysorbate 80,
dioctyl sodium sulpho succinate etc.
STERILE DOSAGE FORM
Ophthalmic drops
Definition Ophthalmic drops (eye drops)
Ophthalmic drops (eye drops) can be defined as they are sterile aqueous or
oily solutions, suspensions, or emulsions intended for instillation into the
conjunctival sac.
Examples of topical eye solutions : Atropine sulphate eye drops. Pilocarpine
eye drops . Silver nitrate eye drops. Zinc sulphate eye drops.
Ideal characteristics
 Ophthalmic drops should be clear and sterile.
 practically free from particles when examined under suitable conditions
of visibility.
 "Water for injections" should be used in the manufacture of aqueous
ophthalmic drops.
STERILE DOSAGE FORM
The preparation of aqueous ophthalmic drops requires
careful consideration of the need for
 Isotonicity.
 A certain buffering capacity.
 The desired pH.
 The addition of antimicrobial agents and/or antioxidants.
 The use of viscosity-increasing agents.
 The choice of appropriate packaging.
STERILE DOSAGE FORM
 Ophthalmic drops are considered isotonic when the tonicity is
equal to that of a 0.9% solution of sodium chloride.
 The eye can usually tolerate solutions equivalent to 0.5-1.8%
of sodium chloride. Ideally, the pH of ophthalmic drops should
be equivalent to that of tear fluid, which is 7.4. However, the
decision to add a buffering agent should be based on stability
considerations.
 The pH selected should be the optimum for both stability of
the active pharmaceutical ingredient and physiological
tolerance. If a buffer system is used, it must not cause
precipitation or deterioration of the active ingredient. The
influence on the lachrymal flow should also be taken into
account.
STERILE DOSAGE FORM
Visual inspection-
 Evidence of physical instability is demonstrated by the
cloudiness of aqueous solutions, due to the formation of a
precipitate.
STERILE DOSAGE FORM
Containers
 Ophthalmic drops are normally supplied in suitable multidose
containers that allow successive drops of the preparation to be
administered.
 The container should be fitted with a tamper-evident device. The
maximum volume of the preparation in such a container should be no
more than 10 mL, unless otherwise specified and authorized.
 Multidose ophthalmic drop preparations may be used for up to 4
weeks after the container is initially opened. Droppers supplied
separately should also comply with Test for sterility.
 Ophthalmic drops may also be provided in suitable single-dose
containers that will maintain the sterility of the contents and the
applicator up to the time of use. It is recommended that single-dose
containers for surgical use should not include any antimicrobial
agents.
STERILE DOSAGE FORM
Formulation of ophthalmic preparation
1)Drug
2)Preservative
3)Sterilization
4) Isotonicity
5)Buffer
6)Viscosity
7)Container
8)Label
STERILE DOSAGE FORM
1) Drugs- T hese contains drugs of various categories
including antiseptic, anti-inflammatory agent, mydriatic
or miotic properties.
2) Preservative- Eye drop should be sterile and should
contain preservatives to avoid microbial contamination
when container is open. The preservative for ophthalmic
use includes benzalkonium chloride, chlorbutanol ,
phenylmercuric acetate, phenylmercuric nitrate etc.,
3) Sterilization- Eye drops are sterilized by autoclaving at
121°C for 15 minutes or by bacteria filter to avoid thermal
degradation for example- preservative chlorbutanol
hydrolyzes at high temperature.
STERILE DOSAGE FORM
4. Isotonicity- All the solutes including drug contribute to the
osmotic pressure of the eye drip, therefore isotonicity of the
formula should be calculated and it is adjusted with sodium
chloride, for example sodium chloride 0.9% and boric acid 1.9&
are iso –osmotic.
5. Viscosity- The size of the drop and its residence in eye depends
on viscosity of eye drops. Methyl cellulose, hydroxypropyl
methycellulose and polyvenyl alcohol are common viscosity
inhancer
6. Buffer- The buffer should be added to maintain balance
between comfort, solubility, stability and activity of drug. For
example the hydrolysed chlorbutanol forms hydrochloride acid
making the drop acidic. Whereas certain drug like pilocarpine
hydrochloride are acidic
STERILE DOSAGE FORM
7. Viscosity- the size of the drop and its residence in eye
depends on viscosity of eye drops. Methyl cellulose,
hydroxypropyl methycellulose and polyvenyl alcohol are
common viscosity inhancer.
8. Container- the commonly used container for ophthalmic
solutions or suspension is multi-dose container(5ml,
10ml). Glass container is supplied with sterile plastic
dropper. Plastic bottles are with built up nozzle
STERILE DOSAGE FORM
9. Label- Not for injection. For external use only. Shake well
before use (if it is suspension)
STERILE DOSAGE FORM
Ophthalmic ointments
 Definition Ophthalmic ointments are sterile,
homogeneous, semi-solid preparations intended for
application to the conjunctiva or the eyelids.
 They are usually prepared from non-aqueous bases, e.g.
soft paraffin (Vaseline), liquid paraffin, and wool fat.
 They may contain suitable additives, such as antimicrobial
agents, antioxidants, and stabilizing agents
 Example of ophthalmic ointment Chloramphenicol
ointment. Tetracycline ointment. Hydrocortisone
ointment.
STERILE DOSAGE FORM
Organoleptic inspection
 Evidence of physical instability is demonstrated by: - a
noticeable change in consistency, such as excessive
"bleeding" (separation of excessive amounts of liquid) or
formation of agglomerates or grittiness; - discoloration; -
emulsion breakdown; - crystal growth; - shrinking due to
evaporation of water; or - evidence of microbial growth.
Uniform consistency
 Ophthalmic ointments should be of uniform consistency.
When a sample is rubbed on the back of the hand, no solid
components should be noticed.
STERILE DOSAGE FORM
Containers
 Ophthalmic ointments are normally supplied in small,
sterilized, collapsible tubes fitted with a tamper-evident
applicator. The containers or the nozzles of the tubes are
shaped so that the ointment can be applied without
contaminating what remains in the tube. The content of such
a container is limited to not more than 5 g of the
preparation. Suitable single-dose containers may also be
used.
Visual inspection
 Evidence of physical instability is demonstrated by the
formation of agglomerates or precipitates in aqueous
solutions (suspensions) that do not disperse when the
solution is shaken gently.
STERILE DOSAGE FORM
Ophthalmic suspensions
 Definition Ophthalmic suspensions contain solid particles dispersed
in a liquid vehicle; they must be homogeneous when shaken gently
and remain sufficiently dispersed to enable the correct dose to be
removed from the container.
 A sediment may occur, but this should disperse readily when the
container is shaken, and the size of the dispersed particles should
be controlled.
 The active ingredient and any other suspended material must be
reduced to a particle size small enough to prevent irritation and
damage to the cornea.
 Examples of eye suspension Prednisolone acetate suspension.
Besifloxacin suspension. Blephamide suspension. Fluorometholone
suspension
STERILE DOSAGE FORM
Visual inspection
 Evidence of physical instability is demonstrated by the
formation of agglomerates or precipitates in aqueous
solutions (suspensions) that do not disperse when the
solution is shaken gently.
STERILE DOSAGE FORM
Contact lens
 Contact lensews are usually made from polymethyl
methacrylate which is hard hydrophobic plastic. Now a
days some softer hydrophilic lenses are also used.
STERILE DOSAGE FORM
Soft contacts
 Soft contact lenses are extremely comfortable and easy to
apply. This type of contact lens stays in place and is easier
to adjust than hard contact lenses. Soft contact lenses are
made out of a flexible plastic that is combined with water
to allow oxygen to flow through the contact lens and to
the cornea. This increases comfort and helps maintain eye
health. In most cases, soft contacts are used to correct
myopia, also known as nearsightedness, hyperopia or
farsightedness, astigmatism or blurred vision, and age
related loss of close-up vision.
 Soft lenses are disposable and there are varieties of soft
lenses available that can be worn for several days before
they need to be removed and discarded.
STERILE DOSAGE FORM
Hard contacts
 Hard contact lenses are the second option of contact lenses available.
These lenses have come a long way since the 1970s. Hard contact lenses
today are rigid gas permeable lenses which allow for more flexibility and
oxygen to pass through the lens to the cornea, while still maintaining their
shape on the eye. Rigid gas permeable contacts have been known to help
slow down the development of nearsightedness in young adults and adult
contact lens wearers. Furthermore, these contact lenses are extremely
durable, easy to care for, handle and wear. They offer clear, crisp vision
and can correct most astigmatism.
 The few disadvantages to hard contact lenses include:
 Vulnerability to scratches
 Can easily dislodge from the center of the eye
 In order to grow accustom to them, you must wear them consistently.
STERILE DOSAGE FORM
Quality control test-
 Metal particles
 Clarity test
 Leackage test
 Sterility test
STERILE DOSAGE FORM
Quality control tests
1. Metal Particles
Metal Particles This test is required only for ophthalmic
ointments. The presence of metal particles will irritate the
corneal or conjunctival surfaces of the eye. It is performed
using 10 ointment tubes. The content from each tube is
completely removed onto a clean 60 - mm - diameter Petri
dish which possesses a flat bottom. The lid is closed and the
product is heated at 85 ° C for 2 h. Once the product is
melted and distributed uniformly, it is cooled to room
temperature. The lid is removed after solidification. The
bottom surface is then viewed through an optical microscope
at 30× magnification
STERILE DOSAGE FORM
2. Leakage test
This test is mandatory for ophthalmic ointments, which
evaluates the intactness of the ointment tube and its seal.
Ten sealed containers are selected, and their exterior
surfaces are cleaned. They are horizontally placed over
absorbent blotting paper . Maintained at 60 ± 3 ° C for 8 h.
The test passes if leakage is not observed from any tube. If
leakage is observed, the test is repeated with an additional
20 tubes. The test passes if not more than 1 tube shows
leakage out of 30 tubes .
STERILE DOSAGE FORM
3. Sterility Tests
Ophthalmic semisolids should be free from anaerobic and
aerobic bacteria and fungi. Sterility tests are therefore
performed by the: 1. Membrane filtration technique . 2.
Direct - inoculation techniques. In the Membrane filtration
method : A solution of test product (1%) is prepared in
isopropyl myristate and allowed to penetrate through
cellulose nitrate filter with pore size less than 0.45 μ m. If
necessary, gradual suction or pressure is applied to aid
filtration.
REFERENCES
 Ophthalmic Dosage Forms Types and Characteristics 1) Liquid ... | Topical
Medication | Chemistry (scribd.com)
 What is Ophthalmic product - Definition, Types & Characteristics
(pharmastudyguide.in)
 OPHTHALMIC PREPARATION(Formulation And Evaluation) |authorSTREAM
 structure of eye - Bing images
 opthalmic dosage form - Bing images
 Soft Contact Lenses vs Hard Contact Lenses | Stanton Optical
 https://resource.lap.recochoku.jp/e8/image/2f02353d603aeda6a97a1bcda02
d7a8d_400_400.jpeg
 https://www.jvstoronto.org/wp-
content/uploads/2017/05/dreamstime_xl_68665429-1-1024x515.jpg

More Related Content

What's hot

parenteral dosage form
parenteral dosage formparenteral dosage form
parenteral dosage form
yogita rayate
 
Tablet types and Excipients
Tablet  types and ExcipientsTablet  types and Excipients
Tablet types and Excipients
Komal Haleem
 
powders and granules presentation
powders and granules presentationpowders and granules presentation
powders and granules presentation
THE ISLAMIA UNIVERSITY OF BAHAWALPUR
 
Parenteral formulations
Parenteral formulationsParenteral formulations
Parenteral formulations
Sayeda Salma S.A.
 
Pharmaceutical aerosols
Pharmaceutical aerosolsPharmaceutical aerosols
Pharmaceutical aerosols
Virendra Vaishnav
 
Parenteral production
Parenteral   productionParenteral   production
Parenteral productionceutics1315
 
ophthalmic products
 ophthalmic products ophthalmic products
ophthalmic products
Md. Mynul Hasan
 
Hard Gelatin Capsule & Soft Gelatin Capsule
Hard Gelatin Capsule & Soft Gelatin CapsuleHard Gelatin Capsule & Soft Gelatin Capsule
Hard Gelatin Capsule & Soft Gelatin Capsule
Genesis Institute of Pharmacy, Radhanagari.
 
Excipients
ExcipientsExcipients
Excipients
Protik Biswas
 
Processing of tablet
Processing of tabletProcessing of tablet
Processing of tablet
Dipak Bhingardeve
 
Basic principles of compounding and dispensing (Containers and closures for d...
Basic principles of compounding and dispensing (Containers and closures for d...Basic principles of compounding and dispensing (Containers and closures for d...
Basic principles of compounding and dispensing (Containers and closures for d...
Imran Nur Manik
 
Glass as Pharmaceutical packaging material
Glass as Pharmaceutical packaging materialGlass as Pharmaceutical packaging material
Glass as Pharmaceutical packaging material
Anil Pethe
 
Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions
Dheeraj Saini
 
Ophthalmic preparations
Ophthalmic preparationsOphthalmic preparations
Ophthalmic preparations
Srikanth Avn
 
Evaluation of ophthalmic preparation
Evaluation of ophthalmic preparationEvaluation of ophthalmic preparation
Evaluation of ophthalmic preparation
Suneal Saini
 
Packaging of pharmaceutical products
Packaging of pharmaceutical productsPackaging of pharmaceutical products
Packaging of pharmaceutical productsSyeda Abeer
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
Liesl Brown
 

What's hot (20)

parenteral dosage form
parenteral dosage formparenteral dosage form
parenteral dosage form
 
Tablet types and Excipients
Tablet  types and ExcipientsTablet  types and Excipients
Tablet types and Excipients
 
powders and granules presentation
powders and granules presentationpowders and granules presentation
powders and granules presentation
 
Parenteral formulations
Parenteral formulationsParenteral formulations
Parenteral formulations
 
Qc tests of ointments
Qc tests of ointmentsQc tests of ointments
Qc tests of ointments
 
Pharmaceutical aerosols
Pharmaceutical aerosolsPharmaceutical aerosols
Pharmaceutical aerosols
 
Parenteral production
Parenteral   productionParenteral   production
Parenteral production
 
ophthalmic products
 ophthalmic products ophthalmic products
ophthalmic products
 
Hard Gelatin Capsule & Soft Gelatin Capsule
Hard Gelatin Capsule & Soft Gelatin CapsuleHard Gelatin Capsule & Soft Gelatin Capsule
Hard Gelatin Capsule & Soft Gelatin Capsule
 
Excipients
ExcipientsExcipients
Excipients
 
Processing of tablet
Processing of tabletProcessing of tablet
Processing of tablet
 
Basic principles of compounding and dispensing (Containers and closures for d...
Basic principles of compounding and dispensing (Containers and closures for d...Basic principles of compounding and dispensing (Containers and closures for d...
Basic principles of compounding and dispensing (Containers and closures for d...
 
Glass as Pharmaceutical packaging material
Glass as Pharmaceutical packaging materialGlass as Pharmaceutical packaging material
Glass as Pharmaceutical packaging material
 
Opthalmic preparation
Opthalmic preparationOpthalmic preparation
Opthalmic preparation
 
Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions
 
Preformulation
PreformulationPreformulation
Preformulation
 
Ophthalmic preparations
Ophthalmic preparationsOphthalmic preparations
Ophthalmic preparations
 
Evaluation of ophthalmic preparation
Evaluation of ophthalmic preparationEvaluation of ophthalmic preparation
Evaluation of ophthalmic preparation
 
Packaging of pharmaceutical products
Packaging of pharmaceutical productsPackaging of pharmaceutical products
Packaging of pharmaceutical products
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
 

Similar to Sterile dosage form (opthalmic)

Opthalmic preparation
Opthalmic preparationOpthalmic preparation
Opthalmic preparation
ibrahimussa
 
OPTHALMIC PRODUCTS.pptx
OPTHALMIC PRODUCTS.pptxOPTHALMIC PRODUCTS.pptx
OPTHALMIC PRODUCTS.pptx
bharatibakde1
 
OPTHALMIC PREPARATION
OPTHALMIC PREPARATIONOPTHALMIC PREPARATION
OPTHALMIC PREPARATION
PoojaPatra16
 
.Ophthalmic preparations
.Ophthalmic preparations.Ophthalmic preparations
.Ophthalmic preparations
MOHIT SHARMA
 
Sterile products
Sterile productsSterile products
Sterile products
shekinah faith balindan
 
Ophthalmic Products
Ophthalmic ProductsOphthalmic Products
Ophthalmic Products
Imran Nur Manik
 
Ophthalmic Preparation.pptx
Ophthalmic Preparation.pptxOphthalmic Preparation.pptx
Ophthalmic Preparation.pptx
DEBASISSEN10
 
Introduction to Ophthalmic products
Introduction to Ophthalmic productsIntroduction to Ophthalmic products
Introduction to Ophthalmic products
Ganesh Derkar
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
Deepak Sarangi
 
eye drops.pptx
 eye drops.pptx eye drops.pptx
eye drops.pptx
SanjaySingh272469
 
Formulation of eye lotions
Formulation of eye lotions Formulation of eye lotions
Formulation of eye lotions
Dheeraj Saini
 
sterile Liquid Non parentral dosage forms
sterile Liquid Non parentral  dosage formssterile Liquid Non parentral  dosage forms
sterile Liquid Non parentral dosage forms
akashpharma19
 
Parenteral Products.pptx
Parenteral Products.pptxParenteral Products.pptx
Parenteral Products.pptx
SreePrakashPandey
 
Formulation of eye lotions
Formulation of eye lotions Formulation of eye lotions
Formulation of eye lotions
Dheeraj Saini
 
Opthalmic product copy
Opthalmic product   copyOpthalmic product   copy
Opthalmic product copy
nirmal marasine
 
Ophthalmic preparations.pptx
Ophthalmic preparations.pptxOphthalmic preparations.pptx
Ophthalmic preparations.pptx
HebaYassin10
 
eye drop and ointment.ppt
eye drop and ointment.ppteye drop and ointment.ppt
eye drop and ointment.ppt
KoushalDhamija1
 
Ophthalmic preparations2
Ophthalmic preparations2Ophthalmic preparations2
Ophthalmic preparations2
Suneal Saini
 
Ophthalmic Preparation
Ophthalmic Preparation Ophthalmic Preparation
Ophthalmic Preparation
Nandakishor Bhaurao Deshmukh
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
Liesl Brown
 

Similar to Sterile dosage form (opthalmic) (20)

Opthalmic preparation
Opthalmic preparationOpthalmic preparation
Opthalmic preparation
 
OPTHALMIC PRODUCTS.pptx
OPTHALMIC PRODUCTS.pptxOPTHALMIC PRODUCTS.pptx
OPTHALMIC PRODUCTS.pptx
 
OPTHALMIC PREPARATION
OPTHALMIC PREPARATIONOPTHALMIC PREPARATION
OPTHALMIC PREPARATION
 
.Ophthalmic preparations
.Ophthalmic preparations.Ophthalmic preparations
.Ophthalmic preparations
 
Sterile products
Sterile productsSterile products
Sterile products
 
Ophthalmic Products
Ophthalmic ProductsOphthalmic Products
Ophthalmic Products
 
Ophthalmic Preparation.pptx
Ophthalmic Preparation.pptxOphthalmic Preparation.pptx
Ophthalmic Preparation.pptx
 
Introduction to Ophthalmic products
Introduction to Ophthalmic productsIntroduction to Ophthalmic products
Introduction to Ophthalmic products
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
 
eye drops.pptx
 eye drops.pptx eye drops.pptx
eye drops.pptx
 
Formulation of eye lotions
Formulation of eye lotions Formulation of eye lotions
Formulation of eye lotions
 
sterile Liquid Non parentral dosage forms
sterile Liquid Non parentral  dosage formssterile Liquid Non parentral  dosage forms
sterile Liquid Non parentral dosage forms
 
Parenteral Products.pptx
Parenteral Products.pptxParenteral Products.pptx
Parenteral Products.pptx
 
Formulation of eye lotions
Formulation of eye lotions Formulation of eye lotions
Formulation of eye lotions
 
Opthalmic product copy
Opthalmic product   copyOpthalmic product   copy
Opthalmic product copy
 
Ophthalmic preparations.pptx
Ophthalmic preparations.pptxOphthalmic preparations.pptx
Ophthalmic preparations.pptx
 
eye drop and ointment.ppt
eye drop and ointment.ppteye drop and ointment.ppt
eye drop and ointment.ppt
 
Ophthalmic preparations2
Ophthalmic preparations2Ophthalmic preparations2
Ophthalmic preparations2
 
Ophthalmic Preparation
Ophthalmic Preparation Ophthalmic Preparation
Ophthalmic Preparation
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
 

More from Anil Deore

To understand weight and measure involved in dispensing.
To understand weight and measure involved in dispensing.To understand weight and measure involved in dispensing.
To understand weight and measure involved in dispensing.
Anil Deore
 
Suppositories and pessaries
Suppositories and pessariesSuppositories and pessaries
Suppositories and pessaries
Anil Deore
 
Sterile dosage form (parenteral)
Sterile dosage form (parenteral)Sterile dosage form (parenteral)
Sterile dosage form (parenteral)
Anil Deore
 
Semisolid dosage form (paste, jellies, and poulties)
Semisolid dosage form (paste, jellies, and poulties)Semisolid dosage form (paste, jellies, and poulties)
Semisolid dosage form (paste, jellies, and poulties)
Anil Deore
 
Semisolid dosage form (ointment)
Semisolid dosage form (ointment)Semisolid dosage form (ointment)
Semisolid dosage form (ointment)
Anil Deore
 
Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
Anil Deore
 
First health
First healthFirst health
First health
Anil Deore
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
Anil Deore
 
Displacement value of suppositories.
Displacement value of suppositories.Displacement value of suppositories.
Displacement value of suppositories.
Anil Deore
 
Envoirment and health
Envoirment and healthEnvoirment and health
Envoirment and health
Anil Deore
 

More from Anil Deore (10)

To understand weight and measure involved in dispensing.
To understand weight and measure involved in dispensing.To understand weight and measure involved in dispensing.
To understand weight and measure involved in dispensing.
 
Suppositories and pessaries
Suppositories and pessariesSuppositories and pessaries
Suppositories and pessaries
 
Sterile dosage form (parenteral)
Sterile dosage form (parenteral)Sterile dosage form (parenteral)
Sterile dosage form (parenteral)
 
Semisolid dosage form (paste, jellies, and poulties)
Semisolid dosage form (paste, jellies, and poulties)Semisolid dosage form (paste, jellies, and poulties)
Semisolid dosage form (paste, jellies, and poulties)
 
Semisolid dosage form (ointment)
Semisolid dosage form (ointment)Semisolid dosage form (ointment)
Semisolid dosage form (ointment)
 
Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
 
First health
First healthFirst health
First health
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
Displacement value of suppositories.
Displacement value of suppositories.Displacement value of suppositories.
Displacement value of suppositories.
 
Envoirment and health
Envoirment and healthEnvoirment and health
Envoirment and health
 

Recently uploaded

Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 

Recently uploaded (20)

Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 

Sterile dosage form (opthalmic)

  • 1. MATOSHRI EDUCATIONS SOCIETY’S M.A.B.D DIPLOMA COLLEGE OF PHARMACY Babhulgaon, Tal.- Yeola, Dist.- Nashik, Maharashtra 423401 PHARMACEUTICS-II STERILE DOSAGE FORM (Ophthalmic Dosage form) By Prof. Mr. Deore A. B M.Pharm (Pharmaceutics)
  • 3. STERILE DOSAGE FORM Ophthalmic dosage form Definition- Ophthalmic dosage form can be defined as they are the sterile dosage form meant for instillation into the eye in the space between eye lids and the eye balls is called as ophthalmic dosage form.
  • 4. STERILE DOSAGE FORM ADVANTAGE:  They are easily administered by the nurse.  They are easily administered by the patient himself.  They have the quick absorption and effect.  less visual and systemic side effects.  Increased shelf life.  better patient compliance.
  • 5. STERILE DOSAGE FORM DISADVANTAGES  The very short time the solution stays at the eye surface.  Its poor bioavailability.  The instability of the dissolved drug.  The necessity of using preservative.
  • 6. STERILE DOSAGE FORM The most important thing about these products are these products must be sterile and should be prepared under the same conditions and by the same methods like other parenteral Parenteral dosage form. Ophthalmic dosage form include-  Eye drops  Eye lotions  Eye ointments  Eye suspension.  Contact lens solutions
  • 7. STERILE DOSAGE FORM Ophthalmic dosage forms Types and characteristics 1) Liquid preparations: (eye drops and eye lotion) 2) Semisolid dosage forms: (ointment creams and gels) applied to the margin of thee yelid or in the conjunctival sac. 3) Solid dosage form: applied to the eye surface to produce modified release dosage form.
  • 8. STERILE DOSAGE FORM Ideal characteristics of Ophthalmic dosage form  Ophthalmic products are required to be sterile and free from particulate matter.  They could be presented as single use or multiple use containers.  If multidose container preservative should be added.  It should have almost neutral pH (pH 7)
  • 9. STERILE DOSAGE FORM Ophthalmic preparations must possess the following properties as mentioned below-  Foreign particles- All the ophthalmic preparations must be free from foreign particles, fibres and filaments. This types of preparations should be clarified very carefully by passing these through bacteria proof filters like membrane filters and sintered glass filters. The paeticle size of the eye suspension should be in an ultra fine state of subdivision to avoid irritations. A separate filter should use for different ophthalmic products to avoid the contamination.
  • 10. STERILE DOSAGE FORM  Viscosity- Various thickening agents are added in the ophthalmic preparation to prolong the contact time of the drug in the eye. Some commonly used thickening agents are polyvinyl alcohol (1-4%), polyethylene glycol, methylcellulose, carboxy methylcellulose etc. These agents improve the viscosity of the ophthalmic preparation.
  • 11. STERILE DOSAGE FORM What are the characteristics of an Ideal thickening agent?  They must be easy to filter.  They should be easy to sterilize.  It should be compatible with other ingredients.  Thickening agents should possess refractive index and clarity level.  The thickening agents are not used in the formulation of eye drops and eye lotions which are used during or after surgery because of some possible adverse effects on the interior of the eye.
  • 12. STERILE DOSAGE FORM  Tonicity- Ophthalmic products should be isotonic with lachrymal secretion to avoid irritation and discomfort. It has been noticed that eye can tolerate tonicity in the range from 0.5 to 2% sodium chloride. There are some isotonic vehicles which are used to prepare ophthalmic preparations like 1.9% boric acid, sodium acid phosphate buffer.
  • 13. STERILE DOSAGE FORM  pH of the preparations- pH plays important role in therapeutic activity, solubility, stability and comfort to the patient. Eye can tolerate solution having wide range of pH provided they are not strongly buffered, since the tears will rapidly restore the normal pH value of the eye. Tears have the pH of 7.4. Alkaloidal salt solutions are stable at pH 2 to 3 but this is irritant to eye. Alkaloids get precipitated at pH above 7 and make problems in the formulations.
  • 14. STERILE DOSAGE FORM  Sterility: The most important properties of the ophthalmic preparation is that they must be sterile when prepared. A very common gram negative bacteria named Pseudomonas aeruginosa which is generally present in the ophthalmic preparations. It may cause serious infection of cornea. It can cause total loss of eye sight within 24-48 hours. To maintain the sterility in multidose container containing ophthalmic preparation a suitable preservative is added. The preservative which is used must be non toxic, non irritant, and must be compatible with the medicaments. The ophthalmic products are sterilised by autoclaving, filtration, addition of bactericide at low temperature and by passing through bacteria proof filters.
  • 15. STERILE DOSAGE FORM  Surface activity- The vehicles which are used in ophthalmic preparation must have good wetting ability to penetrate cornea and other tissues. Certain surfactants or wetting agents are added which are found suitable for ophthalmic preparation. It should not cause any damage to the tissues of eye. Some surfactants which are generally used are benzalkonium chloride, polysorbate 20, polysorbate 80, dioctyl sodium sulpho succinate etc.
  • 16. STERILE DOSAGE FORM Ophthalmic drops Definition Ophthalmic drops (eye drops) Ophthalmic drops (eye drops) can be defined as they are sterile aqueous or oily solutions, suspensions, or emulsions intended for instillation into the conjunctival sac. Examples of topical eye solutions : Atropine sulphate eye drops. Pilocarpine eye drops . Silver nitrate eye drops. Zinc sulphate eye drops. Ideal characteristics  Ophthalmic drops should be clear and sterile.  practically free from particles when examined under suitable conditions of visibility.  "Water for injections" should be used in the manufacture of aqueous ophthalmic drops.
  • 17. STERILE DOSAGE FORM The preparation of aqueous ophthalmic drops requires careful consideration of the need for  Isotonicity.  A certain buffering capacity.  The desired pH.  The addition of antimicrobial agents and/or antioxidants.  The use of viscosity-increasing agents.  The choice of appropriate packaging.
  • 18. STERILE DOSAGE FORM  Ophthalmic drops are considered isotonic when the tonicity is equal to that of a 0.9% solution of sodium chloride.  The eye can usually tolerate solutions equivalent to 0.5-1.8% of sodium chloride. Ideally, the pH of ophthalmic drops should be equivalent to that of tear fluid, which is 7.4. However, the decision to add a buffering agent should be based on stability considerations.  The pH selected should be the optimum for both stability of the active pharmaceutical ingredient and physiological tolerance. If a buffer system is used, it must not cause precipitation or deterioration of the active ingredient. The influence on the lachrymal flow should also be taken into account.
  • 19. STERILE DOSAGE FORM Visual inspection-  Evidence of physical instability is demonstrated by the cloudiness of aqueous solutions, due to the formation of a precipitate.
  • 20. STERILE DOSAGE FORM Containers  Ophthalmic drops are normally supplied in suitable multidose containers that allow successive drops of the preparation to be administered.  The container should be fitted with a tamper-evident device. The maximum volume of the preparation in such a container should be no more than 10 mL, unless otherwise specified and authorized.  Multidose ophthalmic drop preparations may be used for up to 4 weeks after the container is initially opened. Droppers supplied separately should also comply with Test for sterility.  Ophthalmic drops may also be provided in suitable single-dose containers that will maintain the sterility of the contents and the applicator up to the time of use. It is recommended that single-dose containers for surgical use should not include any antimicrobial agents.
  • 21. STERILE DOSAGE FORM Formulation of ophthalmic preparation 1)Drug 2)Preservative 3)Sterilization 4) Isotonicity 5)Buffer 6)Viscosity 7)Container 8)Label
  • 22. STERILE DOSAGE FORM 1) Drugs- T hese contains drugs of various categories including antiseptic, anti-inflammatory agent, mydriatic or miotic properties. 2) Preservative- Eye drop should be sterile and should contain preservatives to avoid microbial contamination when container is open. The preservative for ophthalmic use includes benzalkonium chloride, chlorbutanol , phenylmercuric acetate, phenylmercuric nitrate etc., 3) Sterilization- Eye drops are sterilized by autoclaving at 121°C for 15 minutes or by bacteria filter to avoid thermal degradation for example- preservative chlorbutanol hydrolyzes at high temperature.
  • 23. STERILE DOSAGE FORM 4. Isotonicity- All the solutes including drug contribute to the osmotic pressure of the eye drip, therefore isotonicity of the formula should be calculated and it is adjusted with sodium chloride, for example sodium chloride 0.9% and boric acid 1.9& are iso –osmotic. 5. Viscosity- The size of the drop and its residence in eye depends on viscosity of eye drops. Methyl cellulose, hydroxypropyl methycellulose and polyvenyl alcohol are common viscosity inhancer 6. Buffer- The buffer should be added to maintain balance between comfort, solubility, stability and activity of drug. For example the hydrolysed chlorbutanol forms hydrochloride acid making the drop acidic. Whereas certain drug like pilocarpine hydrochloride are acidic
  • 24. STERILE DOSAGE FORM 7. Viscosity- the size of the drop and its residence in eye depends on viscosity of eye drops. Methyl cellulose, hydroxypropyl methycellulose and polyvenyl alcohol are common viscosity inhancer. 8. Container- the commonly used container for ophthalmic solutions or suspension is multi-dose container(5ml, 10ml). Glass container is supplied with sterile plastic dropper. Plastic bottles are with built up nozzle
  • 25. STERILE DOSAGE FORM 9. Label- Not for injection. For external use only. Shake well before use (if it is suspension)
  • 26. STERILE DOSAGE FORM Ophthalmic ointments  Definition Ophthalmic ointments are sterile, homogeneous, semi-solid preparations intended for application to the conjunctiva or the eyelids.  They are usually prepared from non-aqueous bases, e.g. soft paraffin (Vaseline), liquid paraffin, and wool fat.  They may contain suitable additives, such as antimicrobial agents, antioxidants, and stabilizing agents  Example of ophthalmic ointment Chloramphenicol ointment. Tetracycline ointment. Hydrocortisone ointment.
  • 27. STERILE DOSAGE FORM Organoleptic inspection  Evidence of physical instability is demonstrated by: - a noticeable change in consistency, such as excessive "bleeding" (separation of excessive amounts of liquid) or formation of agglomerates or grittiness; - discoloration; - emulsion breakdown; - crystal growth; - shrinking due to evaporation of water; or - evidence of microbial growth. Uniform consistency  Ophthalmic ointments should be of uniform consistency. When a sample is rubbed on the back of the hand, no solid components should be noticed.
  • 28. STERILE DOSAGE FORM Containers  Ophthalmic ointments are normally supplied in small, sterilized, collapsible tubes fitted with a tamper-evident applicator. The containers or the nozzles of the tubes are shaped so that the ointment can be applied without contaminating what remains in the tube. The content of such a container is limited to not more than 5 g of the preparation. Suitable single-dose containers may also be used. Visual inspection  Evidence of physical instability is demonstrated by the formation of agglomerates or precipitates in aqueous solutions (suspensions) that do not disperse when the solution is shaken gently.
  • 29. STERILE DOSAGE FORM Ophthalmic suspensions  Definition Ophthalmic suspensions contain solid particles dispersed in a liquid vehicle; they must be homogeneous when shaken gently and remain sufficiently dispersed to enable the correct dose to be removed from the container.  A sediment may occur, but this should disperse readily when the container is shaken, and the size of the dispersed particles should be controlled.  The active ingredient and any other suspended material must be reduced to a particle size small enough to prevent irritation and damage to the cornea.  Examples of eye suspension Prednisolone acetate suspension. Besifloxacin suspension. Blephamide suspension. Fluorometholone suspension
  • 30. STERILE DOSAGE FORM Visual inspection  Evidence of physical instability is demonstrated by the formation of agglomerates or precipitates in aqueous solutions (suspensions) that do not disperse when the solution is shaken gently.
  • 31. STERILE DOSAGE FORM Contact lens  Contact lensews are usually made from polymethyl methacrylate which is hard hydrophobic plastic. Now a days some softer hydrophilic lenses are also used.
  • 32. STERILE DOSAGE FORM Soft contacts  Soft contact lenses are extremely comfortable and easy to apply. This type of contact lens stays in place and is easier to adjust than hard contact lenses. Soft contact lenses are made out of a flexible plastic that is combined with water to allow oxygen to flow through the contact lens and to the cornea. This increases comfort and helps maintain eye health. In most cases, soft contacts are used to correct myopia, also known as nearsightedness, hyperopia or farsightedness, astigmatism or blurred vision, and age related loss of close-up vision.  Soft lenses are disposable and there are varieties of soft lenses available that can be worn for several days before they need to be removed and discarded.
  • 33. STERILE DOSAGE FORM Hard contacts  Hard contact lenses are the second option of contact lenses available. These lenses have come a long way since the 1970s. Hard contact lenses today are rigid gas permeable lenses which allow for more flexibility and oxygen to pass through the lens to the cornea, while still maintaining their shape on the eye. Rigid gas permeable contacts have been known to help slow down the development of nearsightedness in young adults and adult contact lens wearers. Furthermore, these contact lenses are extremely durable, easy to care for, handle and wear. They offer clear, crisp vision and can correct most astigmatism.  The few disadvantages to hard contact lenses include:  Vulnerability to scratches  Can easily dislodge from the center of the eye  In order to grow accustom to them, you must wear them consistently.
  • 34. STERILE DOSAGE FORM Quality control test-  Metal particles  Clarity test  Leackage test  Sterility test
  • 35. STERILE DOSAGE FORM Quality control tests 1. Metal Particles Metal Particles This test is required only for ophthalmic ointments. The presence of metal particles will irritate the corneal or conjunctival surfaces of the eye. It is performed using 10 ointment tubes. The content from each tube is completely removed onto a clean 60 - mm - diameter Petri dish which possesses a flat bottom. The lid is closed and the product is heated at 85 ° C for 2 h. Once the product is melted and distributed uniformly, it is cooled to room temperature. The lid is removed after solidification. The bottom surface is then viewed through an optical microscope at 30× magnification
  • 36. STERILE DOSAGE FORM 2. Leakage test This test is mandatory for ophthalmic ointments, which evaluates the intactness of the ointment tube and its seal. Ten sealed containers are selected, and their exterior surfaces are cleaned. They are horizontally placed over absorbent blotting paper . Maintained at 60 ± 3 ° C for 8 h. The test passes if leakage is not observed from any tube. If leakage is observed, the test is repeated with an additional 20 tubes. The test passes if not more than 1 tube shows leakage out of 30 tubes .
  • 37. STERILE DOSAGE FORM 3. Sterility Tests Ophthalmic semisolids should be free from anaerobic and aerobic bacteria and fungi. Sterility tests are therefore performed by the: 1. Membrane filtration technique . 2. Direct - inoculation techniques. In the Membrane filtration method : A solution of test product (1%) is prepared in isopropyl myristate and allowed to penetrate through cellulose nitrate filter with pore size less than 0.45 μ m. If necessary, gradual suction or pressure is applied to aid filtration.
  • 38.
  • 39.
  • 40. REFERENCES  Ophthalmic Dosage Forms Types and Characteristics 1) Liquid ... | Topical Medication | Chemistry (scribd.com)  What is Ophthalmic product - Definition, Types & Characteristics (pharmastudyguide.in)  OPHTHALMIC PREPARATION(Formulation And Evaluation) |authorSTREAM  structure of eye - Bing images  opthalmic dosage form - Bing images  Soft Contact Lenses vs Hard Contact Lenses | Stanton Optical  https://resource.lap.recochoku.jp/e8/image/2f02353d603aeda6a97a1bcda02 d7a8d_400_400.jpeg  https://www.jvstoronto.org/wp- content/uploads/2017/05/dreamstime_xl_68665429-1-1024x515.jpg